To determine if renin angiotensin medications can prevent or delay the onset of diabetic
kidney disease.
Phase:
Phase 2
Details
Lead Sponsor:
Michael Mauer, MD
Collaborators:
Canadian Institutes of Health Research (CIHR) Merck Frosst Canada Ltd. Merck Sharp & Dohme Corp. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)